NewsOur Response to a Massive Fire in Itoigawa City, Niigata

NewsDenka Presents at the 10th Japan-China Energy Conservation and Environment Forum an Agreement to License Its Technologies for Fused Calcium Carbide Transportation

CSR InformationDenka GROUP CSR REPORT 2016

NewsNotice regarding Withdrawal from the Malonic Ester Business

IR InformationFY2016 First Half Summary of Consolidated Financial Results

IR InformationFY2016 First Half Summary of Consolidated Financial Statements

NewsDenka Seiken to Expand Its Healthcare-Related Operations via a Business Alliance with the Taiwan-based PlexBio Co., Ltd.

NewsPrice revision for Denka Chloroprene

IR InformationFY2016 First Quarter Summary of Consolidated Financial Results

IR InformationFY2016 First Quarter Summary of Consolidated Financial Statements

NewsDenka to Establish a Life Science R&D Base in Biopolis in Singapore

NewsDenka Seiken to Establish a Production Facility for the G47Δ Oncolytic Virus

NewsDenka Signs a Comprehensive Industry-Academia Partnership Agreement with Niigata University

IR InformationDenka Corporate Governance Guidelines

IR InformationCorporate Governance Report

NewsDenka to Establish the Automotive Materials & Solutions Department

IR InformationDisclosure on the Internet accompanying the Notice of Convocation of the 157th Ordinary General Meeting of Shareholders

IR InformationNotice of Convocation of the 157th Ordinary General Meeting of Shareholders

NewsNotice regarding a Change in Division Name

NewsDenka Announces "The Denka Value," a New Corporate Philosophy

IR InformationFY2015 Summary of Consolidated Financial Results

IR InformationFY2015 Summary of Consolidated Financial Statements

NewsDenka Acquires Majority Stake in PT ESTOP INDONESIA, Making It a Group Subsidiary

IR InformationNotice Regarding Results of Treasury Stock Acquisition and Completion of Acquisition

NewsCeremonies Marking the 101st Anniversary of Denka's Founding and Welcoming New Employees

IR InformationNotice Regarding Status of Treasury Stock Acquisition

NewsDenka Group Company Denka Seiken Completes a New Manufacturing Facility at Kagamida Plant

NewsDenka Seiken to Commence Clinical Trial of an Intradermal Influenza Vaccine

NewsBEIJING STRONG BIOTECHNOLOGIES Obtains Beijing FDA Approval for the Production and Sale of a Diagnostic Reagent for the Measurement of the sd LDL-C Heart Disease Risk Marker

NewsNotice Regarding Changes in Executive Personnel

IR InformationNotice Regarding Resolution of Treasury Stock Acquisition

NewsDenka to Streamline the Chiba Plant's Utilities to Boost Competitiveness

IR InformationFY2015 Thrid Quarter Summary of Consolidated Financial Results

IR InformationFY2015 Third Quarter Summary of Consolidated Financial Statements

NewsNew Year's Message